Which oral supplements have human evidence for hyperpigmentation and melasma? A clear look at Belight³™, glutathione, pine bark, vitamin C, study quality and why SPF still matters.
The short answer: oral supplements can be useful adjuncts for hyperpigmentation, but the evidence is not equal across ingredients. The clearest direct human data belong to specific studied formulations rather than to a generic list of “brightening vitamins.” A grape–licorice–vitamin C polyphenol complex has two placebo-controlled trials; oral glutathione has mixed evidence; French maritime pine bark has supportive but narrower data; and vitamin C has a strong biological rationale but limited direct evidence as a stand-alone oral pigmentation treatment. None replaces daily photoprotection.
That distinction matters. Search supplements for hyperpigmentation and you will find long lists of antioxidants presented as if they all have the same level of proof. They do not. This guide separates human evidence, mechanism, and marketing extrapolation.
What hyperpigmentation actually is
Hyperpigmentation is an increase in visible pigment. In the epidermis, melanocytes make melanin and transfer pigment to surrounding keratinocytes. The enzyme tyrosinase is central to melanogenesis, which is why many pigmentation strategies — topical or oral — ultimately intersect with tyrosinase, oxidative stress, inflammation, or pigment transfer.
The trigger matters. UV exposure, post-inflammatory pigmentation after acne or irritation, and melasma do not behave identically. Melasma in particular is chronic and multifactorial, so an oral supplement should be understood as an adjunct, not as a substitute for diagnosis, sunscreen, or evidence-based dermatologic care.
The evidence, ranked by what was actually studied
| Oral active | What the human evidence shows | Important caveat |
|---|---|---|
| Belight³™ polyphenol complex | Two randomized, double-blind, placebo-controlled studies evaluated the specific grape seed, grape pomace/viniferin, licorice and vitamin C formulation over 12 weeks — one in 58 Asian participants and one in 66 Caucasian participants with facial dark spots. | The often-quoted 85% tyrosinase inhibition is an in-vitro result, not an 85% reduction in human pigmentation. |
| Glutathione | Several small clinical studies have evaluated oral glutathione. A systematic review found a signal toward reduced melanin index in sun-exposed skin. | The same review concluded that the evidence remained inconclusive because studies were small and results inconsistent. |
| French maritime pine bark | Human studies suggest a possible adjunctive benefit. In one randomized trial in 44 women with melasma, Pycnogenol® added to sunscreen and a topical triple combination improved outcomes more than placebo plus the same background regimen. | This does not prove that every pine-bark extract — or pine bark used alone — will produce the same result. |
| Vitamin C | Vitamin C participates in antioxidant defence and can interfere with melanogenesis. It is also part of the clinically studied Belight³™ combination. | Direct human evidence for stand-alone oral vitamin C as a treatment for facial hyperpigmentation is much weaker than the evidence for the studied combination. |
| Curcumin + piperine | Oral curcumin–piperine has human evidence for effects on inflammatory and oxidative-stress markers. | That is not the same as strong direct clinical evidence for fading hyperpigmentation. It is better described as a supporting mechanism than a proven pigmentation treatment. |
The strongest direct supplement evidence: a specific polyphenol formula
The most convincing supplement evidence in this category does not come from “grape seed” or “vitamin C” in isolation. It comes from a specific oral formulation now known as Belight³™.
In a 2023 randomized, double-blind, placebo-controlled study, 58 Asian adults with visible facial dark spots received the formulation or placebo for 12 weeks. A second randomized, double-blind, placebo-controlled study published in 2025 enrolled 66 Caucasian adults with facial hyperpigmentation and again followed participants for 12 weeks. The latter study reported significant improvements in spectrophotometric dark-spot measurements and clinician-assessed complexion evenness compared with placebo at the study endpoint.
The mechanistic result often used in marketing — 85% inhibition of tyrosinase activity — comes from laboratory testing of the formulation. It is useful for explaining mechanism, but it should not be translated into “85% fewer dark spots” or an equivalent human claim.
Glutathione: plausible, popular — and still mixed
Glutathione is frequently marketed for skin brightening because it can influence oxidative balance and melanogenesis. But the clinical evidence is less tidy than the marketing.
A systematic review of four clinical studies — including oral doses between 250 and 500 mg/day — found some improvement in melanin measurements in sun-exposed skin, while also concluding that the overall evidence remained inconclusive because study quality and results were inconsistent.
That means form and delivery may matter, but it is too strong to say that liposomal delivery, L-cystine or selenium has already “solved” oral glutathione for pigmentation. Those are formulation choices with biological rationale; they are not a substitute for finished-formula clinical evidence.
French maritime pine bark: promising, but read the study design
French maritime pine bark is rich in procyanidins and has been studied orally in pigmentation-related settings. A small randomized placebo-controlled trial in women with melasma found that oral Pycnogenol® improved results when added to a regimen that already contained broad-spectrum sunscreen and a topical triple combination.
That is encouraging evidence for an adjunctive role. It is not evidence that pine bark alone cures melasma, and it should not be generalized automatically to every pine-bark extract.
What about vitamin C by itself?
Vitamin C is important to skin biology and has a credible relationship with melanogenesis, but a common SEO shortcut is to turn that mechanism into a stronger oral-treatment claim than the clinical literature supports.
The better way to say it is: vitamin C is biologically relevant and is part of studied combinations, but the direct evidence for stand-alone oral vitamin C against facial hyperpigmentation is limited. If you want the mechanism in more detail, see does vitamin C fade dark spots?
Why sunscreen still comes first
For sun-induced pigmentation and melasma, continued UV and visible-light exposure can keep reactivating pigment pathways. That is why photoprotection appears repeatedly in clinical protocols and why oral interventions should be positioned as adjuncts.
No supplement replaces photoprotection. If the trigger keeps arriving, the pigment pathway keeps receiving the message.
For melasma, tinted broad-spectrum sunscreen may be particularly relevant because visible light can contribute to relapse in some skin types. A dermatologist can help tailor the regimen to the type and depth of pigmentation.
How long do oral supplements take?
Think in study horizons, not promises. Many oral pigmentation studies assess outcomes at around 8–12 weeks. The Belight³™ trials above used 12 weeks; the Pycnogenol® adjunctive trial used 60 days.
That does not mean every person should expect a visible result on a fixed day. Pigment type, sun exposure, skin tone, adherence, hormonal drivers and the intervention itself all change the timeline.
- Use daily photoprotection. Otherwise new pigment can be triggered while old pigment is fading.
- Photograph consistently. Same room, same time of day, same angle and no beauty filter.
- Judge one intervention over a reasonable interval. Constantly switching products makes it harder to know what helped.
- Escalate persistent or changing pigmentation. New, unusual or treatment-resistant pigmentation deserves professional assessment.
A note on oral tranexamic acid
People searching for “oral supplements for melasma” will often encounter tranexamic acid. It is important not to confuse it with a supplement. Oral tranexamic acid is a medication used off-label for melasma and has a substantially different evidence and safety framework. It requires clinician-led screening for contraindications and thromboembolic risk factors.
If melasma is the primary concern — especially if it is persistent or recurrent — a dermatologist can discuss whether prescription approaches belong in the plan.
Where RADIANCE fits
SKINĒDIT makes RADIANCE, so the commercial relationship should be explicit.
RADIANCE is a 90-day nutricosmetic protocol for dark spots, uneven tone and dullness. It includes BELIGHT³™, liposomal glutathione, L-cystine, curcumin 95%, selenium, French maritime pine bark and BioPerine® within the LumiTech 5™ architecture.
The evidence needs to stay correctly attributed: the randomized studies discussed above evaluated BELIGHT³™ as an ingredient formulation. They are not clinical trials of the finished RADIANCE product. The other RADIANCE ingredients have their own evidence contexts and mechanisms.
Discover RADIANCE The 90-day protocol for dark spots, uneven tone and dullness →
Explore the RADIANCE science experience →
Frequently asked questions
What supplements have the best evidence for hyperpigmentation?
The strongest direct supplement evidence is for specific studied formulations rather than a generic vitamin list. Belight³™, a grape–licorice–vitamin C polyphenol formulation, has two randomized placebo-controlled studies. Oral glutathione and French maritime pine bark also have human data, but their evidence is more mixed or context-dependent.
What are the best oral vitamins for hyperpigmentation?
Vitamin C is biologically relevant to pigmentation, but direct evidence for stand-alone oral vitamin C is limited. The better-supported human evidence comes from multi-ingredient oral formulations in which vitamin C is one component.
Can supplements help melasma?
Some oral supplements have supportive evidence, but melasma is chronic and multifactorial. Supplements are best considered adjuncts to photoprotection and, when needed, dermatologist-directed treatment. Oral tranexamic acid is a medication, not a supplement, and requires medical screening.
How long should I try a pigmentation supplement?
Many studies assess results at 8–12 weeks, so that is a useful evidence horizon rather than a guaranteed personal timeline. Consistent photoprotection and consistent photography make progress easier to judge.
Does RADIANCE have a finished-product clinical trial?
The evidence discussed in this article for BELIGHT³™ comes from studies of the patented ingredient formulation, not a clinical trial of finished RADIANCE. RADIANCE uses BELIGHT³™ as one part of its broader LumiTech 5™ formulation.
Related reading
- Best supplement for melasma: what the evidence says
- Does vitamin C fade dark spots?
- How to fade dark spots from the inside out
References
- Pouchieu C, Pourtau L, Gaudout D, et al. Effect of an Oral Formulation on Skin Lightening: Results from In Vitro Tyrosinase Inhibition to a Double-Blind, Randomized, Placebo-Controlled Clinical Study. Cosmetics. 2023;10(5):143. Study.
- Tursi F, Pourtau L, Roveda G, et al. Clinical Efficacy of Belight3™ on Dark Spot Pigmentation in Caucasian Subjects. Cosmetics. 2025;12(1):27. Study.
- Dilokthornsakul W, Dhippayom T, Dilokthornsakul P. The clinical effect of glutathione on skin color and other related skin conditions: A systematic review. J Cosmet Dermatol. 2019;18(3):728–737. PubMed.
- Lima PB, Dias JAF, Esposito ACC, Miot LDB, Miot HA. French maritime pine bark extract (Pycnogenol) in association with triple combination cream for the treatment of facial melasma in women: a double-blind, randomized, placebo-controlled trial. J Eur Acad Dermatol Venereol. 2021;35(2):502–508. PubMed.
- A Review of Oral Therapies for the Treatment of Skin Hyperpigmentation. PubMed.
- Bala HR, Lee S, Wong C, Pandya AG, Rodrigues M. Oral Tranexamic Acid for the Treatment of Melasma: A Review. Dermatol Surg. 2018;44(6):814–825. PubMed.
Editorial note: This article discusses published evidence and is not medical advice. Persistent, sudden, changing or clinically significant pigmentation should be assessed by a qualified healthcare professional.
Jaouad Bentaguena is the founder of SKINĒDIT Paris. He researches and writes the SKINĒDIT's Intelligence journal himself — working from the peer-reviewed literature and alongside the scientists and clinical partners behind each protocol, to translate the science of deep skincare into something clear enough to act on.
À propos de l’auteur
